Home > News > Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
February 11th, 2004
Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
With nanobiotech research growing at an astounding rate - and funds starting to follow - what are the most promising near-term prospects for nanomedicine? Predicting which applications will have the resources - and luck - to succeed is a dicey proposition, experts acknowledge. But NanoBiotech News posed the questions to the field's preeminent pioneers and found that real-world applications of nanomedicine will happen within five years. Ground-breaking nanotechnology researcher Ralph C. Merkle, Ph.D., and the father of nanomedicine Robert A. Freitas, Jr., JD, are among the industry heavyweights who weighed in with NanoBiotech News on the state of the science and where it's headed.
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013